Thyroid axis function and dysfunction in critical illness

被引:80
作者
Mebis, Liese
Van den Berghe, Greet [1 ,2 ]
机构
[1] Katholieke Univ Leuven, Lab Intens Care Med, Intens Care Med Res Grp, B-3000 Louvain, Belgium
[2] Katholieke Univ Leuven, Lab Intens Care Med, Clin Div, B-3000 Louvain, Belgium
关键词
critical illness; non-thyroidal illness; thyrotropin (TSH); thyrotropin-releasing hormone (TRH); thyroid hormone; deiodinases; nuclear thyroid receptor (TR); retinoid X receptor (RXR); thyroid hormone transporter; hypothalamus; paraventricular nucleus (PVN); PROLONGED CRITICAL ILLNESS; THYROTROPIN-RELEASING-HORMONE; SYSTEMIC INFLAMMATORY RESPONSE; SICK EUTHYROID SYNDROME; TYPE-2 IODOTHYRONINE DEIODINASE; MESSENGER-RNA EXPRESSION; NONTHYROIDAL ILLNESS; ILL PATIENTS; MONOCARBOXYLATE TRANSPORTER-8; SEPTIC SHOCK;
D O I
10.1016/j.beem.2011.03.002
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Acutely ill patients typically present with low circulating T3 and increased reverse T3. When illness is severe and prolonged, also pulsatile TSH secretion and circulating T4 levels are low. This constellation of changes within the thyroid axis is referred to as the low T3 syndrome or non-thyroidal illness syndrome (NTI), and comprises both peripheral and central alterations in the thyroid axis. Acute alterations are dominated by changes in thyroid hormone binding, in thyroid hormone uptake by the cell and in the activity of the type-1 and type-3 deiodinase enzymes. Prolonged critical illness is associated with a neuroendocrine dysfunction characterized by suppressed hypothalamic thyrotropin-releasing hormone (TRH) expression, resulting in reduced stimulation of the thyrotropes whereby thyroidal hormone release is impaired. During prolonged critical illness, several tissue responses could be interpreted as compensatory to low thyroid hormone availability, such as increased expression of monocarboxylate transporters, upregulation of type 2 deiodinase activity and increased sensitivity at the receptor level. Whether the low T3 syndrome should be treated and which compound should be used remains to be further studied. (C) 2011 Elsevier Ltd. All rights reserved.
引用
收藏
页码:745 / 757
页数:13
相关论文
共 90 条
[1]   A trial of thyroxine in acute renal failure [J].
Acker, CG ;
Singh, AR ;
Flick, RP ;
Bernardini, J ;
Greenberg, A ;
Johnson, JP .
KIDNEY INTERNATIONAL, 2000, 57 (01) :293-298
[2]   SERUM LEVELS OF TSH, T3, RT3, T4 AND T3-RESIN UPTAKE IN SURGICAL TRAUMA [J].
ADAMI, HO ;
JOHANSSON, H ;
THOREN, L ;
WIDE, L ;
AKERSTROM, G .
ACTA ENDOCRINOLOGICA, 1978, 88 (03) :482-489
[3]   Selective consumption of thyroxine-binding globulin during cardiac bypass surgery [J].
Afandi, B ;
Schussler, GC ;
Arafeh, AH ;
Boutros, A ;
Yap, MG ;
Finkelstein, A .
METABOLISM-CLINICAL AND EXPERIMENTAL, 2000, 49 (02) :270-274
[4]   Concordant decreases of thyroxine and thyroxine binding protein concentrations during sepsis [J].
Afandi, B ;
Vera, R ;
Schussler, GC ;
Yap, MG .
METABOLISM-CLINICAL AND EXPERIMENTAL, 2000, 49 (06) :753-754
[5]   Distinct tissue-specific roles for thyroid hormone receptors β and α1 in regulation of type 1 deiodinase expression [J].
Amma, LL ;
Campos-Barros, A ;
Wang, ZD ;
Vennström, B ;
Forrest, D .
MOLECULAR ENDOCRINOLOGY, 2001, 15 (03) :467-475
[6]   Association between thyroid function tests at baseline and the outcome of patients with sepsis or septic shock: a systematic review [J].
Angelousi, Anna G. ;
Karageorgopoulos, Drosos E. ;
Kapaskelis, Anastasios M. ;
Falagas, Matthew E. .
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2011, 164 (02) :147-155
[7]   Selenium in Intensive Care (SIC):: Results of a prospective. randomized, placebo-controlled, multiple-center study in patients with severe systemic inflammatory response syndrome, sepsis, and septic shock [J].
Angstwurm, Matthias W. A. ;
Engelmann, Lothar ;
Zimmermann, Thomas ;
Lehmann, Christian ;
Spes, Christoph H. ;
Abel, Peter ;
Strauss, Richard ;
Meier-Hellmann, Andreas ;
Insel, Rudolf ;
Radke, Joachim ;
Schuettler, Juergen ;
Gaertner, Roland .
CRITICAL CARE MEDICINE, 2007, 35 (01) :118-126
[8]   Selenium replacement in patients with severe systemic inflammatory response syndrome improves clinical outcome [J].
Angstwurm, MWA ;
Schottdorf, J ;
Schopohl, J ;
Gaertner, R .
CRITICAL CARE MEDICINE, 1999, 27 (09) :1807-1813
[9]   REDUCED TISSUE THYROID-HORMONE LEVELS IN FATAL ILLNESS [J].
AREM, R ;
WIENER, GJ ;
KAPLAN, SG ;
KIM, HS ;
REICHLIN, S ;
KAPLAN, MM .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1993, 42 (09) :1102-1108
[10]   THE RELATIONSHIP BETWEEN SERUM TRIIODOTHYRONINE AND THYROTROPIN DURING SYSTEMIC ILLNESS [J].
BACCI, V ;
SCHUSSLER, GC ;
KAPLAN, TB .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1982, 54 (06) :1229-1235